SCHEMBL29800720

SCHEMBL29800720

CC(=O)c1ccnc2c([N+](=O)[O-])cccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.60
KMT2A Q03164 8/20 0.60
KDM4E B2RXH2 7/20 0.60
TDP1 Q9NUW8 7/20 0.60
ALDH1A1 P00352 6/20 0.60
MAPT P10636 8/20 0.52
LMNA P02545 4/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
HTT P42858 4/20 0.52
MITF O75030 1/20 0.52
PDE10A Q9Y233 1/20 0.50
CTSB P07858 4/20 0.49
IDO1 P14902 2/20 0.49
TDO2 P48775 2/20 0.49
GAA P10253 2/20 0.49
HSP90AA1 P07900 2/20 0.46
OPRK1 P41145 2/20 0.46
CASP6 P55212 2/20 0.46
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27214168 1.00 MEN1 (0.60) MEN1KMT2AKDM4ETDP1ALDH1A1
SCHEMBL7820257 0.87 KDM4E (0.61) MEN1KMT2AKDM4ETDP1ALDH1A1
SCHEMBL11973794 0.85 PSMD14 (0.61) MEN1KMT2AKDM4ETDP1ALDH1A1
SCHEMBL18434761 0.83 KDM4E (0.57) MEN1KMT2AKDM4ETDP1ALDH1A1
SCHEMBL19220855 0.81 MAPT (0.48) MEN1KMT2AKDM4ETDP1ALDH1A1
SCHEMBL6537393 0.80 MEN1 (0.54) MEN1KMT2AKDM4ETDP1ALDH1A1
SCHEMBL11701285 0.79 MAPT (0.72) MEN1KMT2AKDM4ETDP1ALDH1A1
SCHEMBL8544930 0.79 ALDH1A1 (0.49) MEN1KMT2AKDM4ETDP1ALDH1A1
SCHEMBL4642926 0.78 MEN1 (0.67) MEN1KMT2AKDM4ETDP1ALDH1A1
SCHEMBL6538214 0.78 MAPT (0.77) MEN1KMT2AKDM4ETDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291555-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-12-20 EP disclosed
CN-116806218-A Sulfonamide and its use for the treatment of parasitic helminth infections and diseases 新基公司 2023-09-26 CN disclosed
WO-2022173727-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-08-18 WO disclosed